aastrom
-
Biologics
Aastrom Biosciences Changes Name to Vericel Corporation
Headquarters moved to Cambridge, Mass.; New ticker symbol: VCEL CAMBRIDGE, Mass., November 24, 2014 (GLOBE NEWSWIRE) – Aastrom Biosciences, Inc.…
Read More » -
Biologics
Aastrom Biosciences Announces Plans to Change Name to Vericel Corporation and Move Headquarters to Cambridge, Massachusetts
ANN ARBOR, Mich., Oct. 9, 2014 (GLOBE NEWSWIRE) — Aastrom Biosciences, Inc. (Nasdaq:ASTM), a leading developer of patient-specific expanded cellular…
Read More » -
Biologics
Aastrom Announces Strategic Plan for Recently Acquired Cell Therapy and Regenerative Medicine Business
Manufacturing of MACI in Denmark to be discontinued Sales of MACI in Europe, representing 1% of revenues in 2014, temporarily…
Read More » -
Biologics
AASTROM COMPLETES ACQUISITION OF SANOFI’S CELL THERAPY AND REGENERATIVE MEDICINE BUSINESS
ANN ARBOR, Mich., June 2, 2014 (GLOBE NEWSWIRE) — Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific expanded cellular…
Read More » -
Aastrom Announces Definitive Agreement to Acquire Sanofi’s Cell Therapy and Regenerative Medicine Business
ANN ARBOR, Mich., April 21, 2014 (GLOBE NEWSWIRE) — Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific, expanded multicellular…
Read More »